| Absorption |
| Blood-Brain Barrier | BBB- | 0.7717 |
| Human Intestinal Absorption | HIA+ | 0.7085 |
| Caco-2 Permeability | Caco2- | 0.8778 |
| P-glycoprotein Substrate | Substrate | 0.6683 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8573 |
| Non-inhibitor | 0.9222 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8742 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6483 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7694 |
| CYP450 2D6 Substrate | Non-substrate | 0.8814 |
| CYP450 3A4 Substrate | Non-substrate | 0.5563 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9020 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9552 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9493 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9427 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9417 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8183 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9519 |
| Non-inhibitor | 0.7705 |
| AMES Toxicity | AMES toxic | 0.9503 |
| Carcinogens | Non-carcinogens | 0.9620 |
| Fish Toxicity | High FHMT | 0.7815 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9544 |
| Honey Bee Toxicity | High HBT | 0.6991 |
| Biodegradation | Not ready biodegradable | 0.6544 |
| Acute Oral Toxicity | III | 0.6607 |
| Carcinogenicity (Three-class) | Non-required | 0.6495 |